| Document Date: 2013-12-31 14:02:52
Open Document File Size: 1,82 MBShare Result on Facebook
Currency pence / / MedicalCondition B cell lymphoma model / leukemia / tumor / lymphoma / tumors / disease / Chronic Lymphocytic Leukemia / Most common leukemia / Incurable disease / / MedicalTreatment Active Immunotherapy / chemotherapy / immunotherapy / / Organization FDA / National Institute of Health / UCSD Moores Cancer Center Department of Medicine Division of Bone Marrow & Stem Cell Transplantation / / Person Januario E. Castro / John A. Zaia / David A. Williams / Hildegund Ertl / / Position 2x1010 vp / 2x108 vp / 2x109 vp / vp / vp 2 Jan / Professor / 3x109 vp / 3x1010 vp / 2x1010 and 2x1011 vp / / Product Campath / LacZ Injection / Cyclophosphamide / / SportsEvent NHL / / Technology Transplantation / chemotherapy / /
SocialTag |
ISF35 Active Immunotherapy for Blood Cancer NIH Protocol #[removed]Phase Ib Study of Autologous Ad-‐ISF35-‐Transduced CLL B Cells and Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Subjects with Fludarabin